SCHEMBL6132585

SCHEMBL6132585

CCOC(=O)c1ccccc1N1CCNCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
HTR1A P08908 2/20 0.52
ADRB1 P08588 2/20 0.51
HSD17B10 Q99714 2/20 0.50
GAA P10253 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
ALDH1A1 P00352 1/20 0.49
DRD2 P14416 2/20 0.48
DRD3 P35462 2/20 0.48
HTR3E A5X5Y0 1/20 0.48
HTR3B O95264 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTR3A P46098 1/20 0.48
HTR6 P50406 1/20 0.48
HTR3D Q70Z44 1/20 0.48
HTR3C Q8WXA8 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
DRD4 P21917 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL8435106 0.96 TSHR (0.51) TSHRHTR1AADRB1HSD17B10GAA
SCHEMBL5534929 0.92 TSHR (0.53) TSHRHTR1AADRB1HSD17B10GAA
SCHEMBL5864197 0.89 ADRB1 (0.54) TSHRHTR1AADRB1MAPTALDH1A1
SCHEMBL28965465 0.87 TSHR (0.61) TSHRHTR1AHSD17B10GAASMN1; SMN2
SCHEMBL28353455 0.87 TSHR (0.61) TSHRHTR1AHSD17B10GAASMN1; SMN2
SCHEMBL20930918 0.84 HTR6 (0.58) TSHRHTR1AHSD17B10MAPTALDH1A1
SCHEMBL112024 0.84 ADRB1 (0.55) HTR1AADRB1SMN1; SMN2MAPTDRD2
SCHEMBL30872535 0.83 ALDH1A1 (0.57) TSHRHTR1AMAPK1ALDH1A1HTR6
SCHEMBL6609202 0.83 GAA (0.59) TSHRHTR1AHSD17B10GAAMAPT
SCHEMBL8219392 0.81 ADRB1 (0.49) HTR1AADRB1MAPTDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108290896-B 2-phenyl-3, 4-dihydropyrrolo [2,1-F ] [1,2,4] triazinone derivatives and uses thereof 托帕杜制药公司 2021-09-28 CN disclosed
EP-3708169-A1 2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY Agios Pharmaceuticals, Inc. (US) 2020-09-16 EP disclosed
US-7160886-B2 Acylated piperazine derivatives as melanocortin-4 receptor agonists MERCK & CO., INC. (US) 2007-01-09 US disclosed
US-7160886-B2 Acylated piperazine derivatives as melanocortin-4 receptor agonists MERCK & CO., INC. (US) 2007-01-09 US disclosed
US-6884868-B1 Cyclic hexapeptides having antibiotic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-04-26 US disclosed
EP-1173472-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-23 EP disclosed
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed
WO-2000064927-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 WO disclosed